Activated p38-MAPK and Gemcitabine Sensitivity in Recurrent Ovarian Cancer von KLOTZ, Renate, GUSTAVE ZEIMET, Alain, REIMER, Daniel, MÜLLER-HOLZNER, Elisabeth, CHAMSON, Martina, MARTH, Christian

Volltext

Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients von Muendlein, Axel, Hubalek, Michael, Geller-Rhomberg, Simone, Gasser, Klaus, Winder, Thomas, Drexel, Heinz, Decker, Thomas, Mueller-Holzner, Elisabeth, Chamson, Martina, Marth, Christian, Lang, Alois H

Volltext

Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer von Muendlein, Axel, Lang, Alois H., Geller-Rhomberg, Simone, Winder, Thomas, Gasser, Klaus, Drexel, Heinz, Decker, Thomas, Mueller-Holzner, Elisabeth, Chamson, Martina, Marth, Christian, Hubalek, Michael

Volltext

MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer von HOFSTETTER, Gerda, BERGER, Astrid, ULMER, Hanno, CACSIRE CASTILLO-TONG, Dan, ZEILLINGER, Robert, CONCIN, Nicole, BAUER, Eva-Maria, SCHUSTER, Eva, WOLF, Andrea, CHAMSON, Martina, MÜLLER-HOLZNER, Elisabeth, REIMER, Daniel, BRAICU, Elena I, SEHOULI, Jalid

Volltext